Al-Aly Recognized on TIME100 Health List for Influential Long COVID Research

In a testament to his groundbreaking contributions to global health, Dr. Ziyad Al-Aly , MD, a distinguished clinical epidemiologist at Washington University School of Medicine in St. Louis, has secured a spot on the inaugural TIME100 Health list! This annual list honors individuals whose pioneering work has significantly impacted the landscape of global health.

Dr. Al-Aly's journey to this prestigious acknowledgment is emphasized by his unwavering commitment to understanding the mysteries surrounding long COVID. Through his leadership at the Clinical Epidemiology Center within the Washington University-affiliated Veterans Affairs (VA) St. Louis Health Care System, Dr. Al-Aly has led over two dozen studies exploring the enduring health ramifications experienced by individuals post-COVID-19 infection.

Leveraging the expansive health records database of the U.S. Department of Veterans Affairs , encompassing over 10 million individuals, Dr. Al-Aly has found crucial insights into the multifaceted impacts of SARS-CoV-2 infection. His findings have depicted the heightened risks of long-term complications, spanning cardiac, neurological, renal, gastrointestinal, and mental health domains, confronting COVID-19 survivors.

Dr. Al-Aly's research endeavors are published in several medical journals, including The New England Journal of Medicine, Nature, Science, and JAMA, amassing over 10,000 citations to date. Moreover, his groundbreaking discoveries have garnered widespread acclaim, with coverage in TIME, The New York Times, CNN, and BBC.

You can read the fill story here.

***

In this LinkedIn series, we’ll offer our followers a glimpse into the lesser-known research efforts that are ongoing across the VA. And, if you’re interested in learning more, don’t hesitate to reach out at [email protected].